Literature DB >> 17382325

Modulation of p300 binding by posttranslational modifications of the C-terminal activation domain of hypoxia-inducible factor-1alpha.

Hyunju Cho1, Dae-Ro Ahn, Hyunsung Park, Eun Gyeong Yang.   

Abstract

Posttranslational modifications of hypoxia-inducible factor-1alpha (HIF-1alpha) influence HIF-mediated transcription, likely by affecting binding to p300/cAMP-response element-binding protein (CBP). To systematically analyze the HIF-1alpha-p300/CBP interaction, we developed a fluorescence polarization-based binding assay, employing fluorescein-labeled peptides derived from the C-terminal transactivation domain (C-TAD) of HIF-1alpha. After optimized for effectively capturing p300/CBP, the assay was utilized for evaluating direct effects of posttranslational modifications of the HIF-1alpha C-TAD on p300 binding. The results demonstrated that asparagine hydroxylation and S-nitrosylation of HIF-1alpha decrease p300 binding, while its phosphorylation does not affect p300 binding, which was reconfirmed by competitive inhibition analyses using mutant peptides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382325     DOI: 10.1016/j.febslet.2007.03.015

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

Review 1.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

2.  A compendium of proteins that interact with HIF-1α.

Authors:  Gregg L Semenza
Journal:  Exp Cell Res       Date:  2017-03-20       Impact factor: 3.905

3.  The TIP60 Complex Is a Conserved Coactivator of HIF1A.

Authors:  Joel I Perez-Perri; Veronica L Dengler; K Audrey Audetat; Ahwan Pandey; Elizabeth A Bonner; Marjeta Urh; Jacqui Mendez; Danette L Daniels; Pablo Wappner; Matthew D Galbraith; Joaquín M Espinosa
Journal:  Cell Rep       Date:  2016-06-16       Impact factor: 9.423

Review 4.  Hypoxia inducible factor-1 as a target for neurodegenerative diseases.

Authors:  Z Zhang; J Yan; Y Chang; S ShiDu Yan; H Shi
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

5.  S-nitrosylation in the regulation of gene transcription.

Authors:  Yonggang Sha; Harvey E Marshall
Journal:  Biochim Biophys Acta       Date:  2011-05-24

6.  Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.

Authors:  Hu Huang; Sara Van de Veire; Mansi Dalal; Rachel Parlier; Richard D Semba; Peter Carmeliet; Stanley A Vinores
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

Review 7.  Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases.

Authors:  Tomohiro Nakamura; Olga A Prikhodko; Elaine Pirie; Saumya Nagar; Mohd Waseem Akhtar; Chang-Ki Oh; Scott R McKercher; Rajesh Ambasudhan; Shu-ichi Okamoto; Stuart A Lipton
Journal:  Neurobiol Dis       Date:  2015-03-18       Impact factor: 5.996

Review 8.  Role of nitric oxide in the maintenance of pluripotency and regulation of the hypoxia response in stem cells.

Authors:  Amparo Beltran-Povea; Estefania Caballano-Infantes; Carmen Salguero-Aranda; Franz Martín; Bernat Soria; Francisco J Bedoya; Juan R Tejedo; Gladys M Cahuana
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

9.  Control of HIF-1{alpha} and vascular signaling in fetal lung involves cross talk between mTORC1 and the FGF-10/FGFR2b/Spry2 airway branching periodicity clock.

Authors:  C L Scott; D J Walker; E Cwiklinski; C Tait; A R Tee; S C Land
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-09       Impact factor: 5.464

10.  Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90.

Authors:  Daniela Trisciuoglio; Chiara Gabellini; Marianna Desideri; Elio Ziparo; Gabriella Zupi; Donatella Del Bufalo
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.